network internal website
  
 
... Linking Scientists for Life ...
CardioCell Consortium connects research in London, Bonn, Lund, Paris, Rome and Oxford  
 

European
CardioCell
consortium

Bonn, London, Lund, Oxford, Paris, Rome

  
 

Objective

The major objective of the CardioCell consortium is to retrieve basic science knowledge about cardiomyocyte progenitors and development and adult cardiomyocyte progenitors to develop new strategies for cardiomyocyte replacement therapies for ischemic heart disease. The new knowledge generated from the CardioCell project will both contribute to significant improvements in the prevention and treatment of cardiovascular diseases in Europe and help to maintain European competitiveness in this field of research.
SIGN UP FOR NEWS AND UPDATES
 
Name
E-mail
 

AVAILABLE POSITIONS
 

Post-doc positions are available in:
- Heart development
- Early cardiac progenitors
- Cardiomyocyte physiology
- Transplantation
- Adult cardiac progenitors

Apply now

CONSORTIUM PUBLICATIONS
 

Evidence for cardiomyocyte renewal in humans.
Bergmann et al. Science 2009 324:98-102.

Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia.
Roell et al. Nature 2007 450:819-24.
 
 

Public events

1 October 2010
Report to the Commision

28-30 March 2011
3rd consortium meeting

1 April 2012
Final meeting with report to the Commission

About us
The CardioCell consortium is a network of European scientists collaborating towards improved therapeutic treatments of cardiovascular diseases.

The network is integrated to the European Union's sevenths framework programme.

 
     
Växtkraft © 2007